• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. FLUENCY PLUS ENDOVASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. FLUENCY PLUS ENDOVASCULAR STENT GRAFT Back to Search Results
Model Number FEM08100
Device Problems Misfire (2532); Malposition of Device (2616); Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/06/2023
Event Type  malfunction  
Event Description
It was reported that during a stent placement procedure for the left upper arm loop graft repair of enlarging aneurysm.The stent allegedly partially deployed.The procedure was completed using another device.There was no reported patient injury.
 
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.However, images were provided for review.The investigation of the reported event is currently underway.(expiry date: 08/2025).
 
Manufacturer Narrative
H10: the fda rn number for the mdr 9681442-2023-00061 was inadvertently submitted as 9681442.The correct fda rn number was 2020394.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the fluency stent graft delivery system was returned for evaluation without stent graft as it reportedly has been deployed in the vessel.The radiopaque sheath marker of the system including tip was found without damage, the inner catheter was protruding the tip and the pusher was out of the catheter indicating regular deployment.The origin of the ring shaped piece inside the vessel was not known which leads to inconclusive evaluation results.Also, photos were provided demonstrating deployment of the stent grafts; a ring shaped piece is visible after deployment of the first fluency that was pinned against the wall with the second fluency.A misplacement cannot be evaluated.Both stent grafts are visibly open and not constricted by the ring shaped piece.The images also demonstrate that the secondly placed fluency landed in a curve that was obstructive and that a third stent was placed to smoothen out this curve.An 8f introducer was used for the 9f system, and a system compatible 0.035" guidewire; the proximal end of the stent graft was placed in a straight section of the lumen before deployment, and the system was straightened.Based on the provided information and the evaluation of the returned sample, the investigation is inconclusive.A definite root cause for the reported event could not be determined.Aneurysm treatment represents off label use.Labeling review: in reviewing the relevant labeling, it was found that the instructions for use sufficiently address the potential risks.The instructions for use state: 'if unusual resistance or high deployment force is encountered during stent graft deployment, abort the procedure, remove the delivery system and use an alternative device.' regarding preparation of the device the instructions for use state that 'prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment.' regarding the anatomy of the placement site the instructions for use states: 'prior to stent graft deployment, ensure that the proximal (inflow) stent graft end is positioned in a straight section of the lumen to reduce the risk of higher deployment forces and possible endovascular system failure.' regarding accessories the instructions for use states: 'a super stiff guide wire (0.035 in.) is advanced from a femoral artery puncture site.Use an introducer sheath for the implant procedure'; the packaging pictograms indicate an introducer size of 9f and a 0.035" guidewire.Holding and handling of the system throughout deployment was found sufficiently described.Stent graft misplacement was found mentioned as a potential adverse event.The instructions for use further states: 'the safety and effectiveness of the device when placed across an aneurysm or a pseudoaneurysm has not been evaluated'.H10: d4 (expiry date: 08/2025), g3 h11: b5, h6 (device, method, result, conclusion) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that during a stent placement procedure for the left upper arm loop graft repair of enlarging aneurysm, the stent allegedly detached.It was further reported the device was allegedly malpositioned.The procedure was completed using another device.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Type of Device
ENDOVASCULAR STENT GRAFT
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16478590
MDR Text Key310730610
Report Number9681442-2023-00061
Device Sequence Number1
Product Code PFV
UDI-Device Identifier04049519008516
UDI-Public(01)04049519008516
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFEM08100
Device Catalogue NumberFEM08100
Device Lot NumberANGV3097
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age72 YR
Patient SexMale
-
-